investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Fraser Symmans

1 Collaborator(s)

Funding source

University of Texas MD Anderson Cancer Center

Jonas Bergh

Karolinska Institute

Stockholm, Sweden

Related projects

Zihua Gong

Targeting the DNA repair pathway choice in breast cancer treatment

Breast

Marco Mangone

Detection and validation of miRNA targets in breast cancer

Breast

Pathology

Zhihong Gong

Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities

Breast

Carol A Lange

Inducible PTK6 expression drives oncogenic signaling in breast cancer

Breast

Jeffrey Green

Transgenic Models for Prostate and Breast Cancer

Breast

Joyce M Slingerland

Effects of the PI3K Pathway on p27 Function and Cancer Progression

Breast

Calvin J Kuo

miR-126 Regulation of Tumor Progression

Breast

Andrea Hope Bild

Integrative signaling models to decipher complex cancer phenotypes

Breast

Dihua Yu

Target p70S6K for Chemodietary Prevention/Early Intervention of ER- Breast Cancer

Breast